Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Medical Instrumentation|January 1, 1977
Management considerations in medical equipment acquisitionJ A BlessingGynecologic Oncology|March 1, 1986
Analysis of clinical trials in gynecologic cancer--timing and interpretationJ A Blessing, B AndersonSeminars in Oncology|September 1, 1985
Current therapy of ovarian carcinoma: an overviewT Thigpen, J A BlessingAmerican Journal of Clinical Oncology|February 1, 1988
Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot StudyP Bonomi, E Yordan, J A BlessingGynecologic Oncology|September 10, 1999
Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group studyG Sutton, J A Blessing, H BallAmerican Journal of Clinical Oncology|August 1, 1996
A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group studyR Asbury, J A Blessing, D MooreAmerican Journal of Clinical Oncology|August 1, 1986
ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyH D Homesley, J A Blessing, M BermanGynecologic Oncology|September 28, 2000
Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology GroupR S Mannel, J A Blessing, G BoikeAmerican Journal of Clinical Oncology|December 1, 1993
Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, B DuBeshterAmerican Journal of Clinical Oncology|April 1, 1995
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group studyA Manetta, J A Blessing, K Y LookPageof 18